Venrock Healthcare Capital Partners III, L.P. → Relmada Therapeutics, Inc. RLMD

Stake: — Shares: — Class: Common Stock, $0.001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 8.46

12,990,487 shares short · +22.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $905K

Point72 Asset Mgmt

Other 13D/G Filings on Relmada Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-22	SCHEDULE 13G	MILLENNIUM MANAGEMENT LLC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →